Brookstone Capital Management
ALAB icon

Brookstone Capital Management’s Astera Labs ALAB Stock Holding History

Brookstone Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$401K Sell
1,126
-1,724
-60% -$555K ﹤0.01% 1001
2026
Q2 		$1.38M Buy
+2,850
New +$756K 0.01% 607

Other funds holding ALAB

Salem Investment Counselors
Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Renaissance Capital
Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Oak Grove Capital
Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return
Counterpoint Mutual Funds
Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Brookstone Capital Management's ALAB Position: Q3 2026 in Review

Brookstone Capital Management reduced its Astera Labs (ALAB) stake by 60% in Q3 2026, selling an estimated $555K and leaving 1,126 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Brookstone Capital Management first reported a position in ALAB in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.38M in Q2 2026. 199 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Brookstone Capital Management held 1,126 shares of Astera Labs worth $401K as of Q3 2026.
  • Brookstone Capital Management sold 1,724 Astera Labs shares in Q3 2026, an estimated $555K.
  • Astera Labs made up ﹤0.01% of Brookstone Capital Management's portfolio in Q3 2026, its #1001 holding.
  • Brookstone Capital Management first reported a position in Astera Labs in Q2 2026 and has held it in 2 quarters since.
  • Brookstone Capital Management's Astera Labs position peaked at $1.38M in Q2 2026.
  • 199 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.